Driving Success in Cardiovascular Diagnostic Trials
At CovarsaDx, we’ve earned a solid reputation in respiratory diagnostics, helping companies like OSANG Healthcare, Nuclein, and Healgen bring their […]
At CovarsaDx, we’ve earned a solid reputation in respiratory diagnostics, helping companies like OSANG Healthcare, Nuclein, and Healgen bring their […]
By Clara Feider, PhD, CCRASr. Clinical Research Associate, CovarsaDx The State of Clinical Research in 2025: Navigating Change and Uncertainty
Los Angeles, Calif., February 10, 2025 – CovarsaDx, a prominent Clinical Research Organization (CRO) well-known for its expertise in the areas
CovarsaDx, a leader in IVD and medical device clinical trials, faced a common challenge: efficiently managing vast amounts of complex
CovarsaDx®, a prominent Clinical Research Organization (CRO) renowned for its expertise in the areas of in-vitro diagnostics (IVDs) and medical
CovarsaDx®, a prominent Clinical Research Organization (CRO) renowned for its in vitro diagnostics (IVDs) and medical device expertise, announced today that one of its clinical research study clients, Nuclein, LLC, has received U.S. Food and Drug Administration (FDA) 510(k) clearance and a Clinical Laboratory Improvement Amendments (CLIA) waiver for the DASH® SARS-CoV-2 & Flu A/B Test for use on the DASH® Rapid PCR System.
As we reflect on 2024, CovarsaDx has much to celebrate. This year was marked by milestones that showcased our commitment to advancing diagnostic innovation
Clinical research, especially in the fields of in-vitro diagnostics (IVD) and medical devices, plays a vital role in advancing healthcare solutions and improving public health. However, a pervasive issue facing the industry is the erosion of public trust due to misinformation and past ethical missteps such as the Tuskegee Syphilis Study.
CovarsaDx is thrilled to welcome Tania Vogel to the team as our newest leader in Regulatory and Quality Assurance. With a career spanning nearly two decades and a resume that reads like a blueprint
CovarsaDx is seeking a dedicated and detail-oriented Quality/TMF Administration Assistant to play a pivotal role in managing Trial Master Files